至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Cancer Burden Is Controlled by Mural Cell-β3-Integrin Regulated Crosstalk with Tumor Cells

Cell. 2020-06; 
Wong PP,Muñoz-Félix JM,Hijazi M,Kim H,Robinson SD,De Luxán-Delgado B,Rodríguez-Hernández I,Maiques O,Meng YM,Meng Q,Bodrug N,Dukinfield MS,Reynolds LE,Elia G,Clear A,Harwood C,Wang Y,Campbell JJ,Singh R,Zhang P,Schall TJ,Matchett KP,Henderson NC,Szlosarek PW,Dreger SA,Smith S,Jones JL,Gribben JG,Cutillas PR,Meier P,Sanz-Moreno V,Hodivala-Dilke KM
Products/Services Used Details Operation
Recombinant Proteins /A N/A N/A GenScript USA Inc. Get A Quote

摘要

关键词